BloodPril Side Effects And Safety
The caution statement on this bottle is complete and properly worded. Two warnings a reader taking blood-pressure medicine most needs are not on it anywhere.
Written by the BloodPril editorial team·Last updated October 12, 2026·How this page was checked
Give the bottle its credit first. The caution statement is complete and properly worded: do not exceed recommended dose, and pregnant or nursing mothers, children under the age of 18 and individuals with a known medical condition should consult a physician before using this or any dietary supplement, plus keep out of the reach of children and the safety-seal line. High blood pressure is a known medical condition, so that clause does real work here. Then the two things that are not on it. The clinical summary we opened for arginine, which fills two of the three lines in this blend, records that it may have additive hypotensive effects with blood-pressure medicines and tells patients that taking both at the same time may not be safe. Under Warnings it records that in patients who had an acute myocardial infarction, arginine supplementation may increase risk of mortality. It also notes that long-term supplementation worsened PAD, which matters because the six-bottle pack is about a year. Neither warning appears anywhere in the pack. And because no individual amount is published for any of the three ingredients, nobody outside the company can judge whether the quantity here is large enough to matter. Nothing on this page is a reason to change, reduce or stop a prescribed medicine.
What the bottle says about safety, and it says a lot
The credit comes first: most packs this desk reads have nothing here, and this one has a properly built warning. It is printed in full on the left panel of the wrap.
Do not exceed recommended dose. Pregnant or nursing mothers, children under the age of 18 and individuals with a known medical condition should consult a physician before using this or any dietary supplement. It is joined by KEEP OUT OF THE REACH OF CHILDREN, DO NOT USE IF SAFETY SEAL IS DAMAGED OR MISSING and a storage line.
That covers the four groups a caution panel exists for — pregnancy, nursing, under-18s and people managing a diagnosed condition — and it names the right action: consult a physician before use. Here the fourth clause carries the weight: high blood pressure is a known medical condition, and it is what this product is sold for.
The front of the wrap is disciplined too. One claim, Blood Pressure Support*, using support rather than a drug verb, asterisked to the boxed FDA disclaimer on the same label. Nothing on this bottle says it lowers blood pressure.
Now the two sentences that are not on it. The clinical summary we opened for arginine — the amino acid filling two of the three lines in this blend — carries two warnings a reader of this product would want. Neither is on the wrap, in the artwork, or anywhere in the pack.
Be fair about the limit of that. A general consult a physician clause points a reader at the right person; it cannot tell them what to ask. A buyer who has already discussed their tablets will not know to go back and raise these two things.
Photograph the panel. Three ingredient names, a 500 mg total and a named distributor with a telephone number is enough for the conversation. Add the two quotations below, because the bottle will not raise them. Go before the first capsule.
The two warnings that are not on this bottle
No trial exists on this combination, so no side-effect profile exists for it. What exists is a clinical summary for each amino acid, and one of them matters more than anything else on this site.
The first is an interaction with blood-pressure medicines. The professional section records that arginine “may have additive hypotensive effects” with antihypertensives. The patient-facing section says it plainly: “Arginine supplements can also lower blood pressure so taking both at the same time may not be safe.” This product is sold for blood pressure, so many of the people it is sold to already take tablets for it.
The second is about use after a heart attack. Under Warnings: “In patients who had an acute myocardial infarction, arginine supplementation may increase risk of mortality.” That is a sentence about mortality, in the summary for the ingredient filling two of three lines here. Nothing in the pack references it. If it applies to you, this is a conversation with a cardiologist rather than a purchase.
And one finding about long-term use, because of how this is sold. The same summary notes that while “some studies support the use of arginine in coronary artery and peripheral artery diseases”, “long-term supplementation worsened PAD.” The six-bottle pack is about a year of daily use, bought against a 60-day window, and the pack never prints it.
On citrulline the summary is quieter and the arithmetic is the point instead. The pooled analysis found systolic −4.10 mmHg at 3 to 9 g a day, with the diastolic result not statistically significant overall. The ceiling here is 500 mg. That cuts both ways and it is not a safety argument for taking this: the documented interaction belongs to the other amino acid.
“It is a 500 mg blend of L-citrulline and L-arginine and the individual amounts are not published.” Then: “I have read that arginine may have additive effects with blood-pressure medicines.” The first says what they cannot assume. The second says what to check.
Why nobody can tell you how big any of this is
Every warning above has the same hole in it, and the hole is this label's one gap. An interaction is a question about quantity. A few hundred milligrams of an amino acid and a clinical dose are different propositions for somebody taking tablets, and the summary says so by talking about risk rather than certainty.
No individual amount is published for any of the three ingredients. The panel prints a total and an order, giving ceilings of at most 500, 250 and 167 mg — and a ceiling is not an amount. So nobody outside the company can size the arginine in this capsule: not this desk, not a pharmacist, not the clinician holding your prescription list. We cannot tell you the quantity is too small to matter, and we will not imply the opposite.
That cuts in an uncomfortable direction, and it is the point of this page. With a printed amount a clinician can look at a figure and say that is nothing, carry on. Here the honest answer available to them is I cannot tell from this label. The withheld numbers make the reassurance unavailable.
If you take prescription blood-pressure medicine or anything else that lowers blood pressure, if you have had a heart attack, if you manage peripheral artery disease, or if you are pregnant or nursing: take the panel to whoever manages your prescriptions before you buy, and say that the amounts are not published. Nothing here is a reason to change, reduce or stop anything you have been prescribed.
This site is a U.S. retail partner for BloodPril and earns a commission on orders placed through it, disclosed in the footer of every page. It is why this section is written as plainly as it is: a reader who takes the panel to their prescriber before ordering has been better served by us than by a sale.
The shelf this sits on, and the suffix on the bottle
Two things about the category have to be read against a supplement sold for blood pressure, and the bottle prints one of them correctly.
The first is approval. No dietary supplement is FDA approved, and the agency does not approve supplements before marketing. The bottle claims no such thing: it says manufactured in an FDA registered facility, which is accurate, because registration is a place on a list rather than an examination.
The second is the name. −pril marks the ACE inhibitors, a class of prescription blood-pressure drugs: “These medications most commonly end with the suffix ‘-pril.’ Examples include lisinopril, ramipril, and captopril.” BLOOD PRIL® is a dietary supplement. We allege no intent and print the fact.
Read it as the boundary it is. If there are tablets in your cupboard for your blood pressure, nothing on this page, this site or that bottle is a reason to take fewer of them.
One of the ten supplied reviews makes that point unprompted. Joyce F.: “Showed the bottle to the clinic first. They said keep the tablets.” The brand published it.
And one absence worth naming. No certificate of analysis was supplied — only lot BP-26/BL-4631 and reference BP-4631-26-BL, neither a document. Ask the seller, because the pack does not say.
That is the exact thing the additive-effect note describes. Stop the supplement, keep taking what you were prescribed, and speak to whoever prescribed it. Nothing on this pack will prompt you to make the connection.
Six questions before you order
Nothing is sent anywhere and nothing is stored. The answers stay in your browser.
0 of 6 answered
BloodPril Side Effects And Safety: common questions
What are the side effects?
The bottle carries a proper caution statement: do not exceed the dose; pregnant or nursing mothers, under-18s and individuals with a known medical condition should consult a physician first. That last clause covers most people buying this.<p>The specific thing to know is not on the bottle. See the interaction question below — it is the most useful paragraph on this site.</p>
Is it safe?
The label handles safety better than most: a full caution statement, a storage line, a safety-seal warning, keep out of reach of children. What it does not do is name the two findings a reader of this particular product would want — the additive effect with antihypertensives, and the mortality warning after heart attack. Both are on this site because they are not on the bottle.
Does it interact with any medicines?
From the source we opened, yes — and the relevant one is the class this product is sold alongside. Arginine “may have additive hypotensive effects” with blood-pressure medicines. Because no individual amount is published, nobody can say whether the quantity here is enough to matter, which is itself the reason to ask rather than assume.
I take blood-pressure tablets. Can I take this too?
Ask whoever prescribes them before you buy, not after. The clinical summary we opened says arginine “may have additive hypotensive effects” with antihypertensives, and tells patients directly: “Arginine supplements can also lower blood pressure so taking both at the same time may not be safe.”<p>Nothing on this bottle mentions that. One of the ten reviews supplied with this product is from somebody who takes prescription tablets, showed the bottle to her clinic first, and reports being told to keep taking them.</p>
I have had a heart attack. Is that relevant?
Yes, and specifically. The same clinical summary carries this under Warnings: “In patients who had an acute myocardial infarction, arginine supplementation may increase risk of mortality.” It also records that oral supplementation after a heart attack “did not improve ejection fraction or vascular stiffness, and may be associated with higher mortality.”<p>Nothing anywhere in this product's pack mentions it. If this applies to you, this is a conversation with a cardiologist rather than a purchase.</p>
Will it lower my blood pressure?
Neither we nor the label will tell you that. The bottle says support, not lowers, and carries the disclaimer that it is not intended to treat or prevent any disease. What the research shows is a 4 to 5 mmHg systolic reduction, at doses of 3 to 24 grams a day. This blend is 0.5 grams.
Can I take it if I am pregnant or nursing?
The label says to consult a physician first, and on this it is right. Nothing further is published.
Can under-18s take it?
The label says under-18s should consult a physician before using this or any dietary supplement.
Should I talk to a doctor first?
The label itself says so, for anyone with a known medical condition — and high blood pressure is one, which means most buyers. Take the panel with you. Unlike many products this desk reviews, there is a real panel to take.
If you are going to try BloodPril, try it this way
One bottle is 60 capsules, which at one a day is 60 days — exactly the length of the refund window. No single bottle is sold, so the smallest commitment is two bottles: $158, $1.32 a day, and 120 days of a product whose three individual amounts are not printed.
The struck-through figures are $358, $537 and $1,074 — which is $179 multiplied by two, three and six. A crossed-out price is a claim about what something used to sell for, and no date is given on which this product sold at $179 a bottle. We print the struck figures because they are on the offer, and this note beside them because they are arithmetic rather than history. · window runs from purchase · no subscription · not for under 18, pregnancy or nursing